pharmaceutical tablets

Providing you the best range of calcitonin salmon 200iu calcinase nasal spray, finasteride 5mg fincar 5mg tab and salbutamol 200mcg asthalin rotacaps 200mcg with effective & timely delivery.

CALCITONIN SALMON 200IU CALCINASE NASAL SPRAY

Request Callback

₹ 2018 / Piece Get Latest Price

Dose30 Metered Doses
Packaging Size3.7ml
Packaging TypeBottle
Shelf Life24 Months
Prescription/Non-PrescriptionPrescription
Calcitonin Salmon 200IU Calcinase Nasal Spray is a prescription medication used to treat osteoporosis in postmenopausal women. It helps regulate calcium levels and maintain bone density by inhibiting bone resorption. Easy to use, this nasal spray offers an alternative to oral medications, providing targeted relief with a convenient dosing schedule.

FINASTERIDE 5MG FINCAR 5MG TAB

    Request Callback

    ₹ 248 / Strip Get Latest Price

    Finasteride 5mg Fincar 5mg Tab is a prescription medication used to treat benign prostatic hyperplasia (BPH) in men by reducing prostate size and alleviating associated symptoms. It may also be prescribed for male pattern hair loss. This tablet works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to prostate growth and hair loss.

    SALBUTAMOL 200MCG ASTHALIN ROTACAPS 200MCG

      Request Callback

      ₹ 432 / Box Get Latest Price

      Salbutamol 200mcg Asthalin Rotacaps are inhalation capsules designed to relieve and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). Each capsule contains 200mcg of salbutamol, a bronchodilator that helps relax muscles in the airways, improving airflow and easing breathing. Suitable for use with a Rotahaler device, these rotacaps provide quick relief from wheezing, shortness of breath, and tightness in the chest.
      X

      Contact Us

      Amitrajan Sharma (CEO)
      Savvymeds Healthcare Private Limited
      Capanna-8,Koradi, Road, Ramnath City, Nagpur - 441111, Maharashtra, India

      Get Directions
      Send Email
      Share: